Renol Polychem IPO Details
The key details of Renol Polychem’s IPO are outlined below, covering all crucial aspects from price range to investment requirements and regulatory documents.
| IPO Size | ₹25.77 Cr |
| Price Range | ₹100 - ₹105 |
| Retail Quota | 50% |
| QIB Quota | 35% |
| NII Quota | 15% |
| Employee Discount | -- |
| Listing at | NSE |
| Minimum Quantity | 2,400 |
| Investment (cut-off price) | ₹2,52,000 |
| Pre IPO Promotor Holding | 99.99% |
| Post IPO Promotor Holding | 69.11% |
| DHRP Draft | Click Here |
| RHP Draft | Click Here |
| Anchor Investors List | Click Here |
Renol Polychem IPO Timelines
The IPO process for Renol Polychem includes key dates for participants to know. The timeline allows for strategic planning and participation, helping investors stay informed and engaged throughout the entire process.
31/07/2025
Start Date04/08/2025
End Date06/08/2025
Refund Initiation06/08/2025
Credit of Shares to Demat Ac07/08/2025
Listing DateRenol Polychem IPO Lot Size
The Renol Polychem IPO has a fixed lot size of 1,200 shares, at an upper price band of ₹105 per share. For retail investors, the minimum and maximum application is 2,400 shares (2 lots) amounting to ₹2,52,000. For S-HNI investors, the minimum application is 3,600 shares (3 lots) worth ₹3,78,000, while the maximum is 8,400 shares (7 lots) amounting to ₹8,82,000. B-HNI investors need to apply for at least 9,600 shares (8 lots) totaling ₹10,08,000.
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 | 2400 | ₹2,52,000 |
| Retail Maximum | 2 | 2400 | ₹2,52,000 |
| S-HNI Minimum | 3 | 3600 | ₹3,78,000 |
| S-HNI Maximum | 7 | 8400 | ₹8,82,000 |
| B-HNI Minimum | 8 | 9600 | ₹10,08,000 |
Renol Polychem IPO Subscription Status
The subscription status for Renol Polychem IPO shows market demand across different investor categories, providing valuable insights into the offering’s performance. You can track real-time subscription data below.
| QIB | NII | Retail | EMP | Total |
|---|---|---|---|---|
| 8.41x | 6.89x | 6.51x | -- | 6.83x |
IPO Performance on Listing Day
On its listing day (August 7, 2025), Renol Polychem IPO delivered a weak debut on the exchanges. The stock opened at ₹105, matching the issue price of ₹105. It remained flat during early trade but eventually slipped to an intraday low of ₹99.75, which was also its closing price. With no upward movement and a close below the issue price, the stock ended the day with a 5% loss, indicating subdued investor interest and cautious sentiment toward the chemical manufacturing sector.
| Opening Price | Closing Price | Day High | Day Low |
|---|---|---|---|
| ₹105.00 | ₹99.75 | ₹105.00 | ₹99.75 |
Renol Polychem IPO Company Financials
Renol Polychem reports robust performance in FY2025 with Total Income of ₹62.56 crores, managing expenses at ₹55.90 crores, and achieving a strong PAT (Profit After Tax) of ₹5.00 crores, demonstrating significant growth potential ahead of its public offering.
| Year | Total Income | Total Expense | PAT |
|---|---|---|---|
| FY 2022 | ₹26.8 | ₹26.60 | ₹0.16 |
| FY 2023 | ₹41.86 | ₹40.88 | ₹0.73 |
| FY 2024 | ₹6.52 | ₹4.34 | ₹1.53 |
| FY 2025 | ₹62.56 | ₹55.90 | ₹5.00 |
| FY 2026 (2 M) | ₹12.02 | ₹10.49 | ₹1.14 |
About Company
Renol Polychem Limited, incorporated in 2008, is a specialized manufacturer and supplier of colour masterbatches, plastic masterbatches, industrial chemicals, impact modifiers, and pigments. The company offers an extensive range of colour masterbatches in shades such as green, red, yellow, orange, pink, blue, brown, violet, ivory, white, maroon, silver, multicolor, and black, along with transparent plastic filler masterbatches. Renol also provides all-in-one additives, including stabilisers, impact modifiers, and pigments, tailored for manufacturers of UPVC and CPVC pipes, fittings, and other plastic products.
Their product lineup includes additive masterbatches like UV stabilizers, antioxidants, slip and anti-block agents, processing aids, and flame retardants. They also produce talc and calcium carbonate-based filler masterbatches that enhance mechanical properties and cost efficiency. Additionally, the company supplies high-performance pigments and polymer compounds that improve strength, flexibility, and durability. Renol Polychem’s solutions serve a broad range of industries including plastic packaging, automotive, consumer goods, electronics, textiles, and agriculture. As of September 30, 2024, the company employed 15 people across different departments.
| Incorporation Date | Sector | Managing Director |
|---|---|---|
| 2008 | Chemicals | Bhaveshbhai Harsoda |
Know Before Investing
Renol Polychem IPO Strengths
- The company manufactures a wide variety of masterbatches including black, white, color, additive, and special effect masterbatches like fluorescent and metallic, catering to diverse customer requirements.
- Renol Polychem utilizes state-of-the-art blending and compounding technologies, ensuring consistent product quality and performance across batches.
- Renol Polychem supplies to clients across multiple continents, including Africa and the Middle East, demonstrating international market recognition and export capabilities.
- With a technically knowledgeable staff and R&D capabilities, the company develops tailor-made masterbatch solutions to meet specific needs and improve product performance.
- The company offers environmentally conscious masterbatch solutions in line with the growing demand for sustainable plastic additives in packaging and other industries.
- With increasing industrial usage of masterbatches in packaging, automotive, and consumer goods sectors, Renol Polychem is well-positioned to capitalize on rising demand for quality color and additive solutions.
Renol Polychem IPO Risks
- Over 95 percent of Renol Polychem’s revenue in FY24 comes from Gujarat, Tamil Nadu, and Karnataka. This high dependence on a few regions makes the business vulnerable to regional economic disruptions or regulatory changes.
- The company relies on a limited number of customers and suppliers, often without formal contracts. Losing any major customer or supplier disruptions could adversely affect operations and revenue.
- Price fluctuations in critical raw materials used in manufacturing masterbatches, such as pigments and polymers, can increase production costs. Inability to pass these costs on to customers may compress profit margins.
- Renol Polychem requires substantial working capital for inventory and receivables. Any delays in collections or inventory turnover can strain liquidity and necessitate additional financing.
- The masterbatch and plastic additives industry is competitive, with multiple organized and unorganized players. Intense competition could impact pricing power, margins, and market share.
- Stringent environmental laws and regulations related to plastic usage and chemical manufacturing may impose additional compliance costs or operational restrictions.
Swot Analysis for Renol Polychem IPO
Strengths
Strong Manufacturing and R&D Capabilities, Financial Performance and Efficiency, Wide Client Base and Market Presence
Weaknesses
Modest Scale Compared to Industry Leaders, Regional Concentration, Dependence on Raw Material Prices
Opportunities
Product and Market Diversification, Adoption of Advanced Polymer Solutions, Green and Sustainable Initiatives
Threats
Intense Industry Competition, Regulatory and Environmental Risks, Economic Sensitivity
Company Details
Renol Polychem Ltd.
307, Sanskar Heights NR RA, Circle 150 FT Ring RD, Mavdi, Rajkot, Gujarat- 360004
Phone: +91- 9723780726
Email: compliance@renolpolychem.com
Website: https://www.renolpolychem.com/
IPO Registar Details
Skyline Financial Services Private Ltd
Phone: 02228511022
Email: ipo@skylinerta.com
Website: https://www.skylinerta.com/ipo.php
FAQs
The key objectives of Renol Polychem IPO are:
- Capital Expenditure in requirements for the purchase of Machinery
- Repayment of certain borrowings
- To meet out the Working Capital Requirements
- General Corporate Purposes
Corporate Makers Capital Ltd. is the book-running lead managers for the Renol Polychem IPO.
Renol Polychem has posted strong growth, with revenue rising 49% from ₹41.67 crore in FY23 to ₹62.30 crore in FY25 and net profit increasing nearly 6.8x from ₹0.73 crore to ₹5 crore, supported by improving EBITDA and operational efficiency. A ₹1.14 crore profit in just two months of FY25 further reinforces momentum. While challenges exist in the competitive plastic additives sector, the company’s accelerating profitability and steady scale-up signal solid growth potential ahead.
The issue price for the Renol Polychem IPO is set between ₹100 to ₹105 per share.
To invest in two lot of Renol Polychem IPO, you need ₹2,40,000 at the lower price band (₹100 per share) or ₹2,52,000 at the upper price band (₹105 per share) for a lot size of 2400 shares.
Renol Polychem IPO shares are scheduled to be listed on the National Stock Exchange (NSE) on August 7, 2025.
Refund/unblocking of funds for Renol Polychem IPO will begin on August 6, 2025. ASBA/UPI blocks will be removed within 1 working day.
You can sell shares your Renol Polychem IPO shares on listing day (August 7, 2025) after they are credited to your demat account. If you want to sell in the pre-open market, the timing for that session is from 9:00 AM to 9:15 AM. Otherwise, you can sell after 10:00 AM during regular trading hours.